OHSU in the news

Decriminalization Wasn’t the Real Culprit in Oregon’s Overdose Death Spike

Scientific American October 21, 2024
Scientific American reports on a new study attributing Oregon’s rising rate of illicit drug overdoses to the surge of fentanyl, which arrived on the West Coast later than other areas of the country, and not to the voter initiative that decriminalized drug possession in February 2021. Todd Korthuis, M.D., says, “Fentanyl was the whole story. We need to do a better job lowering the barriers to begin methadone treatment, buprenorphine treatment and creating pathways and systems that support staying on these medications. … This requires an all-hands-on-deck approach from the entire community.”

AACR Congratulates Members Elected to the National Academy of Medicine

American Association for Cancer Research October 21, 2024
In recognition of their contributions to the fields of cancer research, and eye disease diagnosis and care, respectively, Lisa Coussens, Ph.D., and David Huang, M.D., Ph.D., are elected to the National Academy of Medicine. “Dr. Huang and Dr. Coussens have made incredible contributions that have sharpened our understanding of complex health and scientific challenges,” said Danny Jacobs, M.D.

National Academy of Medicine Elects 100 New Members

National Academy of Medicine October 21, 2024
In recognition of their contributions to the fields of cancer research, and eye disease diagnosis and care, respectively, Lisa Coussens, Ph.D., and David Huang, M.D., Ph.D., are elected to the National Academy of Medicine. “Dr. Huang and Dr. Coussens have made incredible contributions that have sharpened our understanding of complex health and scientific challenges,” said Danny Jacobs, M.D.

Nike’s 20th Doernbecher Freestyle Collection Is Packed With Special Details

Yahoo! Life October 19, 2024
Six young patients revealed their personally designed Nike sneakers on Friday, Oct. 18, raising more than $1.5 million to support life-saving care and leading-edge research at Doernbecher Children’s Hospital. Dana Braner, M.D., says, “As we celebrate Doernbecher Freestyle’s 20th anniversary, we also reflect on two extraordinary decades of hope and healing. Each year I am amazed by the strength of these kids, as well as the incredible generosity of our community. This program allows us to support families in need and provide specialized care unavailable anywhere else in the region, and we’re so grateful to everyone who makes this possible.”

New Doernbecher Freestyle Collection Celebrates 20 Years of Empowering Kids Through Design

Nike October 18, 2024
Six young patients revealed their personally designed Nike sneakers on Friday, Oct. 18, raising more than $1.5 million to support life-saving care and leading-edge research at Doernbecher Children’s Hospital. Dana Braner, M.D., says, “As we celebrate Doernbecher Freestyle’s 20th anniversary, we also reflect on two extraordinary decades of hope and healing. Each year I am amazed by the strength of these kids, as well as the incredible generosity of our community. This program allows us to support families in need and provide specialized care unavailable anywhere else in the region, and we’re so grateful to everyone who makes this possible.”

Uneven playing field pushes independent docs to corporate medicine, Oregon panel says

The Lund Report October 17, 2024
In a The Lund Report article about concern over the growing corporate influence on health care, and its effects on patients and providers, Jane Zhu, M.D., says there are arguments that corporations may bring efficiencies that help patients, and it is difficult to say whether corporate ownership of medicine is inherently good or bad. A better question, she says, is what policies can curb the trend’s “worst outcomes.”

These Real-world Safety Protocols Are Underway for Anti-amyloid Therapies

Neurology Today October 17, 2024
In a Neurology Today story weighing the pros and cons of new anti-amyloid therapies for Alzheimer’s disease, Lisa Silbert, M.D., says, “We have a low threshold for obtaining additional MRIs for patients on anti-amyloid therapy with new neurologic symptoms. Our team has also had many different educational outreach events with our emergency department to educate them about monoclonal antibody therapies, as well as with colleagues within the neurology department, many of whom will be on call if one of our patients should have after-hours neurologic symptoms.”
See more stories